The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
CMS Launches Aggressive Crackdown on New York Social Adult Day Care Fraud on October 22, 2026 Posted by
The Silent Epidemic: Stroke Rates Surge Among Younger Adults, Challenging Traditional Medical Wisdom on October 22, 2026 Posted by
The Battle for Bodily Autonomy: Idaho’s High-Stakes Referendum on Abortion Rights on October 22, 2026 Posted by
The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
Posted in Digital Health Tools A New Horizon for Rare Disease: FDA Approval of Lisraya Marks a Turning Point for Dermatomyositis Patients on September 5, 2026
Posted in Digital Health Tools A New Era for Dermatomyositis: Roivant Sciences Secures Historic FDA Approval for Lisraya on August 28, 2026
Posted in Medical Innovations A Breakthrough for Rare Disease: FDA Approves Lisraya for Dermatomyositis on August 28, 2026
Posted in Medical Innovations A New Era in Rheumatology: FDA Approves First Oral Therapy for Dermatomyositis on August 28, 2026
Posted in Medical Innovations A New Frontier in Dermatomyositis: FDA Approval of Lisraya Marks a Pivot Point for Roivant on August 27, 2026
Posted in Medical Innovations Bridging the Gap: How New Validation of IMACS Guidelines Could Revolutionize Cancer Screening in Dermatomyositis Patients on July 11, 2026
